Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

UNCY stock hub

Unicycive Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

UNCYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

200.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

UNCY

In the news

Latest news · UNCY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-141.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-96

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All UNCY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001766140
Company name	Unicycive Therapeutics, Inc.
Country	United States
Country code	US
Cusip	90466Y202
Employees	22
Employees Change	-1%
Employees Change Percent	-4.35
Enterprise value	$159.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-13
Isin	US90466Y2028
Last refreshed	2026-05-10
Market cap	$200.4M
Market cap category	Micro-Cap
Price	$7.94
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	UNCY
Website	https://unicycive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.25%
FCF yield	-15.64%
P/B ratio	5.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-26.6M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	$-1.2M
ROA	-45.66
Roa5y	-89.95
ROCE	-97.75
ROE	-141.1
ROIC	-96.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	24.65%
Cagr3y	-16%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$49.1M
Cash	$41.3M
Current Assets	$49M
Current Liabilities	$18.9M
Debt	$117,000
Debt Equity	$0
Equity	$30.2M
Interest Coverage	-415.7
Liabilities	$18.9M
Long Term Assets	$174,000
Long Term Liabilities	$0
Net Cash	$41.2M
Net Cash By Market Cap	$20.54
Net Cash Growth	61.63%
Net Debt Equity	$-1.36
Tangible Book Value	$30.2M
Tangible Book Value Per Share	$1.37
WACC	14.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.59
Net Working Capital	$-11.1M
Quick ratio	2.18
Working Capital	$30M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-137.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	24.63%
200-day SMA	5.7
3Y total return	-40.75%
50-day SMA	7.03
50-day SMA vs 200-day SMA	50over200
All Time High	87.3
All Time High Change	-90.9%
All Time High Date	2021-07-13
All Time Low	2.02
All Time Low Change	293.07%
All Time Low Date	2024-08-13
ATR	0.4
Beta	1.77
Beta1y	1.96
Beta2y	1.62
Ch YTD	37.61
High	8.14
High52	11
High52 Date	2025-06-09
High52ch	-27.82%
Low	7.78
Low52	3.71
Low52 Date	2025-09-25
Low52ch	114.02%
Ma50ch	13.01%
Premarket Change Percent	1.43
Premarket Price	$7.97
Premarket Volume	7,884
Price vs 200-day SMA	39.35%
RSI	62.29
RSI Monthly	52.51
RSI Weekly	64.82
Sharpe ratio	0.7x
Sortino ratio	0.99
Total Return	-137.17%
Tr YTD	37.61
Tr1m	18.86%
Tr1w	3.52%
Tr3m	18.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$40
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.49
Earnings Revenue Estimate	14,285,710x
Operating Income	$-29.5M
Price target	$25.67
Price Target Change	$223
Price Target Change Top	$404

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,818,351%
Float Percent	90.41%
Shares Insiders	2.49%
Shares Institutions	26.33%
Shares Out	25,237,782
Shares Qo Q	18.63%
Shares Yo Y	137.17%
Short Float	9.47%
Short Ratio	4.07
Short Shares	8.56

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-34M
Average Volume	549,884.1x
Bv Per Share	1.37
CAPEX	$-24,000
Ch1m	18.86
Ch1w	3.52
Ch1y	24.63
Ch3m	18.69
Ch3y	-40.75
Ch6m	71.86
Change	1.02%
Change From Open	0
Close	7.86
Days Gap	1.02
Depreciation Amortization	34,000
Dollar Volume	3,189,212.2
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$-29.5M
EBITDA	$-29.5M
EPS	$-1.67
F Score	1
FCF	$-31.3M
FCF EV Yield	-19.68x
FCF Per Share	$-1.24
Financing CF	46,468,000
Fiscal Year End	December
Founded	2,016
Investing CF	-12,095,000
Ipr	58.8
Iprfo	-90.71
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Date	2025-06-20
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	6.19
Ma150ch	28.38%
Ma20	7.42
Ma20ch	7.07%
Net CF	3,056,000
Next Earnings Date	2026-05-22
Open	7.94
Optionable	Yes
Position In Range	44.44
Post Close	7.94
Postmarket Change Percent	-0.35
Postmarket Price	$7.91
Ppne	174,000
Pre Close	7.86
Price Date	2026-05-08
Ptbv Ratio	6.64
Relative Volume	0.73x
Share Based Comp	2,641,000
Tr6m	71.86%
Us State	California
Volume	401,664

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does UNCY pay a dividend?

Capital-return profile for this ticker.

Performance

UNCY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns UNCY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.3%

Float: +90.4% of shares outstanding

Insider ownership

+2.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

UNCY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.3

Neutral momentum band

Price vs 200-day MA

+39.3%

50/200-day relationship not available

Beta (5Y)

1.77

More volatile than the market

Sharpe ratio

0.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About UNCY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current UNCY stock rating?

Unicycive Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full UNCY analysis?

The full report lives at /stocks/UNCY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for UNCY?

The latest report frames UNCY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the UNCY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.